These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7230164)

  • 1. Association of Behçet's syndrome with HLA-B5 in the Mexican mestizo population.
    Lavalle C; Alarcon-Segovia D; Del Giudice-Knipping JA; Fraga A
    J Rheumatol; 1981; 8(2):325-7. PubMed ID: 7230164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of Behçet's syndrome in a rural area in northern Turkey.
    Yurdakul S; Günaydin I; Tüzün Y; Tankurt N; Pazarli H; Ozyazgan Y; Yazici H
    J Rheumatol; 1988; 15(5):820-2. PubMed ID: 3172095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease.
    Soto-Vega E; García-Muñoz R; Richaud-Patin Y; Zúñiga-Ramos J; Crispín JC; Díaz-Jouanen E; Flores-Suárez LF; Llorente L; Granados J
    Immunol Lett; 2004 May; 93(2-3):211-5. PubMed ID: 15158619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high prevalence of HLA-B5 in Behçet's disease.
    Yazici H; Akokan G; Yalçin B; Müftüoğlu A
    Clin Exp Immunol; 1977 Nov; 30(2):259-61. PubMed ID: 606446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behcet's disease and associations with HLA-B5 antigen (a review of literature and the authors' findings)].
    Goloeva RG; Alekberova ZS; Guseva IA; Krylov MIu
    Ter Arkh; 2010; 82(5):45-9. PubMed ID: 20597270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histocompatibility antigens in patients with Behçet's disease.
    Haim S; Gideoni O; Barzilai A
    Acta Derm Venereol; 1977; 57(3):243-5. PubMed ID: 71830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The HLA pattern in Adamantiades-Behçet's disease in Germany. Association of occurrence, clinical symptoms and follow-up in 39 patients].
    Zouboulis CC; Büttner P; Djawari D; Kirch W; Keitel W; Garbe C; von Keyserlingk-Eberius HJ; Orfanos CE
    Hautarzt; 1993 Feb; 44(2):81-5. PubMed ID: 8449698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HLA typing in patients of German origin with recurrent benign aphthosis and Behçet's disease].
    Djawari D; Lang B; Hornstein OP
    Z Hautkr; 1984 Aug; 59(15):1005-9. PubMed ID: 6485449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relationship of the HLA antigen system to Behçet's disease].
    Golosenko IIu
    Vestn Dermatol Venerol; 1990; (5):55-7. PubMed ID: 2402945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey.
    Yazici H; Tuzun Y; Pazarli H; Yalcin B; Yurdakul S; Muftuoglu A
    J Rheumatol; 1980; 7(2):206-10. PubMed ID: 7373623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between HLA B5 and ocular involvement in Behçet's disease in southern Turkey.
    Soylu M; Ersöz TR; Erken E
    Acta Ophthalmol (Copenh); 1992 Dec; 70(6):786-9. PubMed ID: 1488888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen in Sweet's syndrome and its relationship to Behçet's disease.
    Mizoguchi M; Matsuki K; Mochizuki M; Watanabe R; Ogawa K; Harada S; Hino H; Amagai M; Juji T
    Arch Dermatol; 1988 Jul; 124(7):1069-73. PubMed ID: 3389850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prevalence of HLA-B5 antigen in Behçet's disease].
    Hamza M; Ben Ayed H; Sohier R; Betuel H
    Nouv Presse Med; 1978 Oct; 7(36):3263. PubMed ID: 733499
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behçet's disease. II. Etiopathogenetic and therapeutic aspects. Personal observations].
    Lovisetto P; Monteverde A; Cargnino M; Cadario G; Biarese V; Marchi L; Catania E
    Minerva Med; 1984 Oct; 75(39):2263-82. PubMed ID: 6334250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I and class II genotyping in patients with Behcet's disease: a regional study of eastern part of Turkey.
    Pirim I; Atasoy M; Ikbal M; Erdem T; Aliagaoglu C
    Tissue Antigens; 2004 Sep; 64(3):293-7. PubMed ID: 15304011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes.
    Lehner T; Welsh KI; Batchelor JR
    Immunology; 1982 Dec; 47(4):581-7. PubMed ID: 6958639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA antigens and certain types of uveitis.
    Crews SJ; Mackintosh P; Barry DR; Willshaw HE
    Trans Ophthalmol Soc U K (1962); 1979 Apr; 99(1):156-9. PubMed ID: 297369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The epidemiology of Behcet's syndrome].
    Hamza M; Ben Ayed H
    Tunis Med; 1979; 57(4-5):184-6. PubMed ID: 555084
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran.
    Rajaei E; Jalali MT; Pezeshki SMS; Rezaeeyan H; Maniati M; Elyasi M; Zayeri ZD
    Curr Rheumatol Rev; 2020; 16(2):120-124. PubMed ID: 31533601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunogenetic basis for the tissue involvement in Behçet's syndrome.
    Lehner T; Batchelor JR; Challacombe SJ; Kennedy L
    Immunology; 1979 Aug; 37(4):895-900. PubMed ID: 500134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.